Physician profile
Emily M Wolf
NPI 1720739543
$1,160.80
in general payments reported to CMS, 2019-2025
23 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $184 · 2023: $370 · 2024: $354 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $136.43 | 2024 | |
| Abbvie INC. | $129.43 | 2023-2024 | |
| Bioventus LLC | $105.37 | 2022-2023 | Supartz Fx Sodium Hyaluronate |
| Immunitybio, INC. | $104.17 | 2025 | |
| Sumitomo Pharma America, INC. | $74.99 | 2024-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $69.60 | 2023-2025 | Lynparza, Keytruda |
| Astellas Pharma US INC | $67.35 | 2024 | Xtandi |
| Ferring Pharmaceuticals INC. | $66.75 | 2022-2024 | Adstiladrin, Euflexxa |
| Pfizer INC. | $49.00 | 2023 | |
| Sun Pharmaceutical Industries INC. | $43.29 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.64 | 2023 | |
| Olympus America INC. | $36.01 | 2025 | Itind System |
| Teleflex LLC | $30.94 | 2023-2024 | Urolift |
| Depuy Synthes Sales INC. | $28.71 | 2022 | |
| Boston Scientific Corporation | $27.53 | 2025 | Polaris Ultra |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.42 | 2023 | Interstim |
| Janssen Biotech, INC. | $25.32 | 2023 | Erleada |
| Fidia Pharma USA INC. | $23.30 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.26 | 2023 | |
| Averitas Pharma INC. | $16.26 | 2023 | Qutenza |
| Avanos Medical | $15.33 | 2022 | |
| Accord Healthcare, INC. | $15.15 | 2025 | |
| Axonics, INC. | $13.55 | 2023 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.